Benefit of Expanded Surveillance of Nursing Homes During the COVID-19 Pandemic

CompletedOBSERVATIONAL
Enrollment

1,587

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

December 15, 2020

Study Completion Date

June 30, 2021

Conditions
COVID-19 Respiratory InfectionSARS-CoV-2 Infection
Interventions
DIAGNOSTIC_TEST

Nasopharyngeal swab for SARS-CoV-2

in the interventional group, regular, i.e. twice to three times weekly, SARS-CoV-2 testing was offered to health-care workers and visitors of nursing homes

Trial Locations (1)

50937

University Hospital Cologne, Cologne

All Listed Sponsors
collaborator

City Council of Cologne, Department of Public Health, NRW, Germany

UNKNOWN

collaborator

City Council of Cologne, Department of Social Affairs, Health and Environment, NRW, Germany

UNKNOWN

lead

University of Cologne

OTHER

NCT04933981 - Benefit of Expanded Surveillance of Nursing Homes During the COVID-19 Pandemic | Biotech Hunter | Biotech Hunter